Interstitial granulomatous drug reaction to adalimumab.
Martorell-Calatayud
Antonio
A
Balmer
Nicole
N
Cardenas Cardona
Luis Fernando
LF
Teague
Daniel
D
D000068879:Adalimumab; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000009:adverse effects*; D015535:Arthritis, Psoriatic / Q000188:drug therapy; D003875:Drug Eruptions / Q000209:etiology / Q000378:metabolism / Q000473:pathology*; D005260:Female; D006099:Granuloma / Q000209:etiology / Q000378:metabolism / Q000473:pathology; D006801:Humans; D007150:Immunohistochemistry; D008875:Middle Aged; D013848:Thigh / Q000473:pathology
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D000068879:Adalimumab